These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12102580)

  • 21. Introduction to molecular combing: genomics, DNA replication, and cancer.
    Herrick J; Bensimon A
    Methods Mol Biol; 2009; 521():71-101. PubMed ID: 19563102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacogenomics genomics approaches to optimizing drug therapy].
    Shi J; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Novel approaches; improved diagnostics and therapeutics with DNA microarrays. II. Applications].
    Linn SC; van de Rijn M; Giaccone G
    Ned Tijdschr Geneeskd; 2003 Apr; 147(17):800-4. PubMed ID: 12741168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput genomics in sorghum: from whole-genome resequencing to a SNP screening array.
    Bekele WA; Wieckhorst S; Friedt W; Snowdon RJ
    Plant Biotechnol J; 2013 Dec; 11(9):1112-25. PubMed ID: 23919585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The International HapMap Project.
    International HapMap Consortium
    Nature; 2003 Dec; 426(6968):789-96. PubMed ID: 14685227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single nucleotide polymorphism array analysis of cancer.
    Dutt A; Beroukhim R
    Curr Opin Oncol; 2007 Jan; 19(1):43-9. PubMed ID: 17133111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Host genetic epidemiology by single nucleotide polymorphism(SNP) analysis].
    Shin HD
    Exp Mol Med; 2001 Apr; 33(1 Suppl):51-69. PubMed ID: 11708326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of single nucleotide polymorphisms in the isolation of common disease genes.
    Riley JH; Allan CJ; Lai E; Roses A
    Pharmacogenomics; 2000 Feb; 1(1):39-47. PubMed ID: 11258595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
    Robert J
    J Chemother; 2004 Nov; 16 Suppl 4():22-4. PubMed ID: 15688604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomics in breast cancer: current trends and future directions.
    Wajapeyee N; Somasundaram K
    Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics and disease genetics of complex diseases.
    Schmith VD; Campbell DA; Sehgal S; Anderson WH; Burns DK; Middleton LT; Roses AD
    Cell Mol Life Sci; 2003 Aug; 60(8):1636-46. PubMed ID: 14504654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput microarray technologies: from genomics to clinics.
    Bubendorf L
    Eur Urol; 2001 Aug; 40(2):231-8. PubMed ID: 11528203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using high-throughput SNP technologies to study cancer.
    Engle LJ; Simpson CL; Landers JE
    Oncogene; 2006 Mar; 25(11):1594-601. PubMed ID: 16550159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [I. Single nucleotide polymorphism in human genetic analyses].
    Czerska K; Nawara M; Bal J
    Med Wieku Rozwoj; 2003; 7(4 Pt 2):531-46. PubMed ID: 15213368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarrays to identify new therapeutic strategies for cancer.
    Sears C; Armstrong SA
    Adv Cancer Res; 2007; 96():51-74. PubMed ID: 17161676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primer: genomic and proteomic tools for the molecular dissection of disease.
    Walker EJ; Siminovitch KA
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics.
    Hoehe MR; Timmermann B; Lehrach H
    Curr Pharm Biotechnol; 2003 Dec; 4(6):351-78. PubMed ID: 14683431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Lineage addiction" in human cancer: lessons from integrated genomics.
    Garraway LA; Weir BA; Zhao X; Widlund H; Beroukhim R; Berger A; Rimm D; Rubin MA; Fisher DE; Meyerson ML; Sellers WR
    Cold Spring Harb Symp Quant Biol; 2005; 70():25-34. PubMed ID: 16869735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SNP technologies for drug discovery: a current review.
    Voisey J; Morris CP
    Curr Drug Discov Technol; 2008 Sep; 5(3):230-5. PubMed ID: 18690891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.